Role of tyrosine kinase signaling in endothelial cell barrier regulation

Vascular Pharmacology

Volumn 39, Issue 4-5, 2002, Pages 201-212

  Bogatcheva, Natalia V ^a   Garcia, Joe G N ^a   Verin, Alexander D ^a  

^a JOHNS HOPKINS ASTHMA AND ALLERGY CENTER   (United States)

Author keywords

Cell barrier; Phosphorylation; Tyrosine kinase

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; BISINDOLYLMALEIMIDE; CELL SURFACE RECEPTOR; PROTEIN TYROSINE KINASE; SB 203508; UO 126; CELL ADHESION MOLECULE;

CELL MEMBRANE PERMEABILITY; CYTOSKELETON; ENDOTHELIUM CELL; GENE TRANSLOCATION; HUMAN; LEUKOCYTE; MACROMOLECULE; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; CELL JUNCTION; ENZYMOLOGY; METABOLISM; PHYSIOLOGY; VASCULAR ENDOTHELIUM;

ANIMALS; CELL ADHESION MOLECULES; CELL MEMBRANE PERMEABILITY; CYTOSKELETON; ENDOTHELIUM, VASCULAR; HUMANS; INTERCELLULAR JUNCTIONS; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION;

EID: 0042845701     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1537-1891(03)00009-0     Document Type: Review

References (104)

1. Abedi H., Zachary I. Vascular endothelial growth factor stimulates tyrosine phosphorylation and recruitment to new focal adhesions of focal adhesion kinase and paxillin in endothelial cells. J. Biol. Chem. 272:1997;15442-15451.
2. Abram C.L., Courtneidge S.A. Src family tyrosine kinases and growth factor signaling. Exp. Cell Res. 254:2000;1-13.
3. Abu-Ghazaleh R., Kabir J., Jia H., Lobo M., Zachary I. Src mediates stimulation by vascular endothelial growth factor of the phosphorylation of focal adhesion kinase at tyrosine 861, and migration and anti-apoptosis in endothelial cells. Biochem. J. 360:2001;255-264.
4. Andriopoulou P., Navarro P., Zanetti A., Lampugnani M.G., Dejana E. Histamine induces tyrosine phosphorylation of endothelial cell-to-cell adherens junctions. Arterioscler. Thromb. Vasc. Biol. 19:1999;2286-2297.
5. Becker P.M., Verin A.D., Booth M.A., Liu F., Birukova A., Garcia J.G. Differential regulation of diverse physiological responses to VEGF in pulmonary endothelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 281:2001;L1500- L1511.
6. Bellis S.L., Miller J.T., Turner C.E. Characterization of tyrosine phosphorylation of paxillin in vitro by focal adhesion kinase. J. Biol. Chem. 270:1995;17437-17441.
7. Ben Mahdi M.H., Andrieu V., Pasquier C. Focal adhesion kinase regulation by oxidative stress in different cell types. IUBMB Life. 50:2000;291-299.
8. Berk B.C. Redox signals that regulate the vascular response to injury. Thromb. Haemost. 82:1999;810-817.
9. Birukov K.G., Csortos C., Marzilli L., Dudek S., Ma S.F., Bresnick A.R., Verin A.D., Cotter R.J., Garcia J.G. Differential regulation of alternatively spliced endothelial cell myosin light chain kinase isoforms by p60(Src). J. Biol. Chem. 276:2001;8567-8573.
10. Burridge K., Chrzanowska-Wodnicka M., Zhong C. Focal adhesion assembly. Trends Cell Biol. 7:1997;342-347.
11. Bussolino F., Mantovani A., Persico G. Molecular mechanisms of blood vessel formation. Trends Biochem. Sci. 22:1997;251-256.
12. Chen H.C., Guan J.L. Association of focal adhesion kinase with its potential substrate phosphatidylinositol 3-kinase. Proc. Natl. Acad. Sci. U. S. A. 91:1994;10148-10152.
13. Cohen A.W., Carbajal J.M., Schaeffer R.C. VEGF stimulates tyrosine phosphorylation of beta-catenin and small-pore endothelial barrier dysfunction. Am. J. Physiol. 277:1999;H2038-H2049.
14. Cross D.A., Alessi D.R., Cohen P., Andjelkovich M., Hemmings B.A. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature. 378:1995;785-789.
15. D'Angelo G., Graceffa P., Wang C.A., Wrangle J., Adam L.P. Mammal-specific, ERK-dependent, caldesmon phosphorylation in smooth muscle. Quantitation using novel anti-phosphopeptide antibodies. J. Biol. Chem. 274:1999;30115-30121.
16. Dikic I., Tokiwa G., Lev S., Courtneidge S.A., Schlessinger J. A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation. Nature. 383:1996;547-550.
17. Dirks W.G., MacLeod R.A., Drexler H.G. ECV304 (endothelial) is really T24 (bladder carcinoma): cell line cross-contamination at source. In Vitro Cell. Dev. Biol. Anim. 35:1999;558-559.
18. Eliceiri B.P. Integrin and growth factor receptor crosstalk. Circ. Res. 89:2001;1104-1110.
19. Eliceiri B.P., Puente X.S., Hood J.D., Stupack D.G., Schlaepfer D.D., Huang X.Z., Sheppard D., Cheresh D.A. Src-mediated coupling of focal adhesion kinase to integrin alpha(v)beta5 in vascular endothelial growth factor signaling. J. Cell Biol. 157:2002;149-160.
20. Essler M., Amano M., Kruse H.J., Kaibuchi K., Weber P.C., Aepfelbacher M. Thrombin inactivates myosin light chain phosphatase via Rho and its target Rho kinase in human endothelial cells. J. Biol. Chem. 273:1998;21867-21874.
21. Farooki A.Z., Epstein D.L., O'Brien E.T. Tyrphostins disrupt stress fibers and cellular attachments in endothelial monolayers. Exp. Cell Res. 243:1998;185-198.
22. Ferkey D.M., Kimelman D. GSK-3: new thoughts on an old enzyme. Dev. Biol. 225:2000;471-479.
23. Fleming I., Fisslthaler B., Busse R. Interdependence of calcium signaling and protein tyrosine phosphorylation in human endothelial cells. J. Biol. Chem. 271:1996;11009-11015.
24. Fong G.H., Zhang L., Bryce D.M., Peng J. Increased hemangioblast commitment, not vascular disorganization, is the primary defect in flt-1 knock-out mice. Development. 126:1999;3015-3025.
25. Fujii E., Irie K., Ohba K., Ogawa A., Yoshioka T., Yamakawa M., Muraki T. Role of nitric oxide, prostaglandins and tyrosine kinase in vascular endothelial growth factor-induced increase in vascular permeability in mouse skin. Naunyn-Schmiedeberg's Arch. Pharmacol. 356:1997;475-480.
26. Garcia J.G., Davis H.W., Patterson C.E. Regulation of endothelial cell gap formation and barrier dysfunction: role of myosin light chain phosphorylation. J. Cell. Physiol. 163:1995;510-522.
27. Garcia J.G., Verin A.D., Schaphorst K., Siddiqui R., Patterson C.E., Csortos C., Natarajan V. Regulation of endothelial cell myosin light chain kinase by Rho, cortactin, and p60(src). Am. J. Physiol. 276:1999;L989-L998.
28. Garcia J.G., Schaphorst K.L., Verin A.D., Vepa S., Patterson C.E., Natarajan V. Diperoxovanadate alters endothelial cell focal contacts and barrier function: role of tyrosine phosphorylation. J. Appl. Physiol. 89:2000;2333-2343.
29. Garcia J.G., Liu F., Verin A.D., Birukova A., Dechert M.A., Gerthoffer W.T., Bamberg J.R., English D. Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement. J. Clin. Invest. 108:2001;689-701.
30. Gerwins P., Skoldenberg E., Claesson-Welsh L. Function of fibroblast growth factors and vascular endothelial growth factors and their receptors in angiogenesis. Crit. Rev. Oncol. Hematol. 34:2000;185-194.
31. Gilbert-McClain L.I., Verin A.D., Shi S., Irwin R.P., Garcia J.G. Regulation of endothelial cell myosin light chain phosphorylation and permeability by vanadate. J. Cell. Biochem. 70:1998;141-155.
32. Gille H., Kowalski J., Li B., LeCouter J., Moffat B., Zioncheck T.F., Pelletier N., Ferrara N. Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). A reassessment using novel receptor-specific vascular endothelial growth factor mutants. J. Biol. Chem. 276:2001;3222-3230.
33. Goeckeler Z.M., Wysolmerski R.B. Myosin light chain kinase-regulated endothelial cell contraction: the relationship between isometric tension, actin polymerization, and myosin phosphorylation. J. Cell Biol. 130:1995;613-627.
34. Gozin A., Franzini E., Andrieu V., Da Costa L., Rollet-Labelle E., Pasquier C. Reactive oxygen species activate focal adhesion kinase, paxillin and p130cas tyrosine phosphorylation in endothelial cells. Free Radic. Biol. Med. 25:1998;1021-1032.
35. Guo D., Jia Q., Song H.Y., Warren R.S., Donner D.B. Vascular endothelial cell growth factor promotes tyrosine phosphorylation of mediators of signal transduction that contain SH2 domains. Association with endothelial cell proliferation. J. Biol. Chem. 270:1995;6729-6733.
36. Hattan D., Nesti E., Cachero T.G., Morielli A.D. Tyrosine phosphorylation of Kv1.2 modulates its interaction with the actin binding protein cortactin. J. Biol. Chem. 277:2002;38596-38606.
37. Hiratsuka S., Minowa O., Kuno J., Noda T., Shibuya M. Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. Proc. Natl. Acad. Sci. U. S. A. 95:1998;9349-9354.
38. Huang C., Ni Y., Wang T., Gao Y., Haudenschild C.C., Zhan X. Down-regulation of the filamentous actin cross-linking activity of cortactin by Src-mediated tyrosine phosphorylation. J. Biol. Chem. 272:1997;13911-13915.
39. Huot J., Houle F., Marceau F., Landry J. Oxidative stress-induced actin reorganization mediated by the p38 mitogen-activated protein kinase/heat shock protein 27 pathway in vascular endothelial cells. Circ. Res. 80:1997;383-392.
40. Isagawa T., Mukai H., Oishi K., Taniguchi T., Hasegawa H., Kawamata T., Tanaka C., Ono Y. Dual effects of PKNalpha and protein kinase C on phosphorylation of tau protein by glycogen synthase kinase-3beta. Biochem. Biophys. Res. Commun. 273:2000;209-212.
41. Ito N., Huang K., Claesson-Welsh L. Signal transduction by VEGF receptor-1 wild type and mutant proteins. Cell. Signal. 13:2001;849-854.
42. Jiang W.G., Martin T.A., Matsumoto K., Nakamura T., Mansel R.E. Hepatocyte growth factor/scatter factor decreases the expression of occludin and transendothelial resistance (TER) and increases paracellular permeability in human vascular endothelial cells. J. Cell. Physiol. 181:1999;319-329.
43. Johansen J.W., Ingebritsen T.S. Effects of phosphorylation of protein phosphatase 1 by pp60v-src on the interaction of the enzyme with substrates and inhibitor proteins. Biochim. Biophys. Acta. 928:1987;63-75.
44. Katsube T., Takahisa M., Ueda R., Hashimoto N., Kobayashi M., Togashi S. Cortactin associates with the cell-cell junction protein ZO-1 in both Drosophila and mouse. J. Biol. Chem. 273:1998;29672-29677.
45. Keogh R.J., Houliston R.A., Wheeler-Jones C.P. Thrombin-stimulated Pyk2 phosphorylation in human endothelium is dependent on intracellular calcium and independent of protein kinase C and Src kinases. Biochem. Biophys. Res. Commun. 294:2002;1001-1008.
46. Kevil C.G., Payne D.K., Mire E., Alexander J.S. Vascular permeability factor/vascular endothelial cell growth factor-mediated permeability occurs through disorganization of endothelial junctional proteins. J. Biol. Chem. 273:1998;15099-15103.
47. Klemke R.L., Cai S., Giannini A.L., Gallagher P.J., de Lanerolle P., Cheresh D.A. Regulation of cell motility by mitogen-activated protein kinase. J. Cell Biol. 137:1997;481-492.
48. Kroll J., Waltenberger J. The vascular endothelial growth factor receptor KDR activates multiple signal transduction pathways in porcine aortic endothelial cells. J. Biol. Chem. 272:1997;32521-32527.
49. Lampugnani M.G., Corada M., Andriopoulou P., Esser S., Risau W., Dejana E. Cell confluence regulates tyrosine phosphorylation of adherens junction components in endothelial cells. J. Cell. Sci. 110:1997;2065-2077.
50. 2-mediated injury of human endothelial cells. J. Biol. Chem. 275:2000;37187-37193.
51. Liu F., Verin A.D., Wang P., Day R., Wersto R.P., Chrest F.J., English D.K., Garcia J.G. Differential regulation of sphingosine-1-phosphate- and VEGF-induced endothelial cell chemotaxis. Involvement of g(ialpha2)-linked rho kinase activity. Am. J. Respir. Cell Mol. Biol. 24:2001;711-719.
52. Liu F., Schaphorst K.L., Verin A.D., Jacobs K., Birukova A., Day R.M., Bogatcheva N., Bottaro D.P., Garcia J.G. Hepatocyte growth factor enhances endothelial cell barrier function and cortical cytoskeletal rearrangement: potential role of glycogen synthase kinase-3beta. FASEB J. 16:2002;950-962.
53. Lowes V.L., Ip N.Y., Wong Y.H. Integration of signals from receptor tyrosine kinases and g protein-coupled receptors. NeuroSignals. 11:2002;5-19.
54. Luttrell L.M., Daaka Y., Lefkowitz R.J. Regulation of tyrosine kinase cascades by G-protein-coupled receptors. Curr. Opin. Cell Biol. 11:1999;177-183.
55. Marsen T.A., Simonson M.S., Dunn M.J. Thrombin-mediated ET-1 gene regulation involves CaM kinases and calcineurin in human endothelial cells. J. Cardiovasc. Pharmacol. 26:1995;S1-S4.
56. McNiven M.A., Kim L., Krueger E.W., Orth J.D., Cao H., Wong T.W. Regulated interactions between dynamin and the actin-binding protein cortactin modulate cell shape. J. Cell Biol. 151:2000;187-198.
57. Mehta D., Tiruppathi C., Sandoval R., Minshall R.D., Holinstat M., Malik A.B. Modulatory role of focal adhesion kinase in regulating human pulmonary arterial endothelial barrier function. J. Physiol. 539:2002;779-789.
58. Minshall R.D., Tiruppathi C., Vogel S.M., Malik A.B. Vesicle formation and trafficking in endothelial cells and regulation of endothelial barrier function. Histochem. Cell Biol. 117:2002;105-112.
59. Olazabal I.M., Machesky L.M. Abp1p and cortactin, new "hand-holds" for actin. J. Cell Biol. 154:2001;679-682.
60. Ozawa K., Kashiwada K., Takahashi M., Sobue K. Translocation of cortactin (p80/85) to the actin-based cytoskeleton during thrombin receptor-mediated platelet activation. Exp. Cell Res. 221:1995;197-204.
61. Paul R., Zhang Z.G., Eliceiri B.P., Jiang Q., Boccia A.D., Zhang R.L., Chopp M., Cheresh D.A. Src deficiency or blockade of Src activity in mice provides cerebral protection following stroke. Nat. Med. 7:2001;222-227.
62. Pawson T., Scott J.D. Signaling through scaffold, anchoring, and adaptor proteins. Science. 278:1997;2075-2080.
63. Pierce K.L., Luttrell L.M., Lefkowitz R.J. New mechanisms in heptahelical receptor signaling to mitogen activated protein kinase cascades. Oncogene. 20:2001;1532-1539.
64. Plopper G.E., McNamee H.P., Dike L.E., Bojanowski K., Ingber D.E. Convergence of integrin and growth factor receptor signaling pathways within the focal adhesion complex. Mol. Biol. Cell. 6:1995;1349-1365.
65. Rebecchi M.J., Pentyala S.N. Structure, function, and control of phosphoinositide-specific phospholipase C. Physiol. Rev. 80:2000;1291-1335.
66. Roberts W.G., Palade G.E. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J. Cell. Sci. 108(Pt. 6):1995;2369-2379.
67. Rodriguez-Fernandez J.L. Why do so many stimuli induce tyrosine phosphorylation of FAK? BioEssays. 21:1999;1069-1075.
68. Rosen E.M., Goldberg I.D. Scatter factor and angiogenesis. Adv. Cancer Res. 67:1995;257-279.
69. Rousseau S., Houle F., Landry J., Huot J. p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells. Oncogene. 15:1997;2169-2177.
70. Rubinfeld B., Albert I., Porfiri E., Fiol C., Munemitsu S., Polakis P. Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly. Science. 272:1996;1023-1026.
71. Sachs M., Brohmann H., Zechner D., Muller T., Hulsken J., Walther I., Schaeper U., Birchmeier C., Birchmeier W. Essential role of Gab1 for signaling by the c-Met receptor in vivo. J. Cell Biol. 150:2000;1375-1384.
72. Schaller M.D. Paxillin: a focal adhesion-associated adaptor protein. Oncogene. 20:2001;6459-6472.
73. Schaphorst K.L., Pavalko F.M., Patterson C.E., Garcia J.G. Thrombin-mediated focal adhesion plaque reorganization in endothelium: role of protein phosphorylation. Am. J. Respir. Cell Mol. Biol. 17:1997;443-455.
74. Schlaepfer D.D., Hanks S.K., Hunter T., van der Geer P. Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase. Nature. 372:1994;786-791.
75. Schlaepfer D.D., Hauck C.R., Sieg D.J. Signaling through focal adhesion kinase. Prog. Biophys. Mol. Biol. 71:1999;435-478.
76. Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell. 103:2000;211-225.
77. Schuuring E., van Damme H., Schuuring-Scholtes E., Verhoeven E., Michalides R., Geelen E., de Boer C., Brok H., van Buuren V., Kluin P. Characterization of the EMS1 gene and its product, human cortactin. Cell Adhes. Commun. 6:1998;185-209.
78. Seetharam L., Gotoh N., Maru Y., Neufeld G., Yamaguchi S., Shibuya M. A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF. Oncogene. 10:1995;135-147.
79. Shalaby F., Rossant J., Yamaguchi T.P., Gertsenstein M., Wu X.F., Breitman M.L., Schuh A.C. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature. 376:1995;62-66.
80. Shi S., Verin A.D., Schaphorst K.L., Gilbert-McClain L.I., Patterson C.E., Irwin R.P., Natarajan V., Garcia J.G. Role of tyrosine phosphorylation in thrombin-induced endothelial cell contraction and barrier function. Endothelium. 6:1998;153-171.
81. Shi S., Garcia J.G., Roy S., Parinandi N.L., Natarajan V. Involvement of c-Src in diperoxovanadate-induced endothelial cell barrier dysfunction. Am. J. Physiol. Lung Cell Mol. Physiol. 279:2000;L441-L451.
82. Simionescu M., Gafencu A., Antohe F. Transcytosis of plasma macromolecules in endothelial cells: a cell biological survey. Microsc. Res. Tech. 57:2002;269-288.
83. Sozeri O., Vollmer K., Liyanage M., Frith D., Kour G., Mark G.E. III, Stabel S. Activation of the c-Raf protein kinase by protein kinase C phosphorylation. Oncogene. 7:1992;2259-2262.
84. Stuart K.A., Riordan S.M., Lidder S., Crostella L., Williams R., Skouteris G.G. Hepatocyte growth factor/scatter factor-induced intracellular signalling. Int. J. Exp. Pathol. 81:2000;17-30.
85. Su L., Zhao Z., Bouchard P., Banville D., Fischer E.H., Krebs E.G., Shen S.H. Positive effect of overexpressed protein-tyrosine phosphatase PTP1C on mitogen-activated signaling in 293 cells. J. Biol. Chem. 271:1996;10385-10390.
86. Sutherland C., Leighton I.A., Cohen P. Inactivation of glycogen synthase kinase-3 beta by phosphorylation: new kinase connections in insulin and growth-factor signalling. Biochem. J. 296(1 Pt. 1):1993;15-19.
87. Tachibana K., Sato T., D'Avirro N., Morimoto C. Direct association of pp125FAK with paxillin, the focal adhesion-targeting mechanism of pp125FAK. J. Exp. Med. 182:1995;1089-1099.
88. Takahashi T., Ueno H., Shibuya M. VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cells. Oncogene. 18:1999;2221-2230.
89. Tallquist M.D., Soriano P., Klinghoffer R.A. Growth factor signaling pathways in vascular development. Oncogene. 18:1999;7917-7932.
90. Tilghman R.W., Hoover R.L. The Src-cortactin pathway is required for clustering of E-selectin and ICAM-1 in endothelial cells. FASEB J. 16:2002;1257-1259.
91. Turner C.E. Paxillin interactions. J. Cell. Sci. 113:2000;4139-4140.
92. Ukropec J.A., Hollinger M.K., Salva S.M., Woolkalis M.J. SHP2 association with VE-cadherin complexes in human endothelial cells is regulated by thrombin. J. Biol. Chem. 275:2000;5983-5986.
93. Vepa S., Scribner W.M., Parinandi N.L., English D., Garcia J.G., Natarajan V. Hydrogen peroxide stimulates tyrosine phosphorylation of focal adhesion kinase in vascular endothelial cells. Am. J. Physiol. 277:1999;L150-L158.
94. Vouret-Craviari V., Bourcier C., Boulter E., Van Obberghen-Schilling E. Distinct signals via Rho GTPases and Src drive shape changes by thrombin and sphingosine-1-phosphate in endothelial cells. J. Cell. Sci. 115:2002;2475-2484.
95. Wojciak-Stothard B., Potempa S., Eichholtz T., Ridley A.J. Rho and Rac but not Cdc42 regulate endothelial cell permeability. J. Cell. Sci. 114:2001;1343-1355.
96. Wong E.Y., Morgan L., Smales C., Lang P., Gubby S.E., Staddon J.M. Vascular endothelial growth factor stimulates dephosphorylation of the catenins p120 and p100 in endothelial cells. Biochem. J. 346(Pt. 1):2000;209-216.
97. Wu H., Parsons J.T. Cortactin, an 80/85-kilodalton pp60src substrate, is a filamentous actin-binding protein enriched in the cell cortex. J. Cell Biol. 120:1993;1417-1426.
98. Wu H.M., Yuan Y., Zawieja D.C., Tinsley J., Granger H.J. Role of phospholipase C, protein kinase C, and calcium in VEGF-induced venular hyperpermeability. Am. J. Physiol. 276:1999;H535-H542.
99. Wu L.W., Mayo L.D., Dunbar J.D., Kessler K.M., Ozes O.N., Warren R.S., Donner D.B. VRAP is an adaptor protein that binds KDR, a receptor for vascular endothelial cell growth factor. J. Biol. Chem. 275:2000;6059-6062.
100. Yamboliev I.A., Gerthoffer W.T. Modulatory role of ERK MAPK-caldesmon pathway in PDGF-stimulated migration of cultured pulmonary artery SMCs. Am. J. Physiol. Cell Physiol. 280:2001;C1680-C1688.
101. Yuan Y., Meng F.Y., Huang Q., Hawker J., Wu H.M. Tyrosine phosphorylation of paxillin/pp125FAK and microvascular endothelial barrier function. Am. J. Physiol. 275:1998;H84-H93.
102. Zhang L., Himi T., Morita I., Murota S. Hepatocyte growth factor protects cultured rat cerebellar granule neurons from apoptosis via the phosphatidylinositol-3 kinase/Akt pathway. J. Neurosci. Res. 59:2000;489-496.
103. Zhao Z., Tan Z., Wright J.H., Diltz C.D., Shen S.H., Krebs E.G., Fischer E.H. Altered expression of protein-tyrosine phosphatase 2C in 293 cells affects protein tyrosine phosphorylation and mitogen-activated protein kinase activation. J. Biol. Chem. 270:1995;11765-11769.
104. Zhao Z., Tan Z., Diltz C.D., You M., Fischer E.H. Activation of mitogen-activated protein (MAP) kinase pathway by pervanadate, a potent inhibitor of tyrosine phosphatases. J. Biol. Chem. 271:1996;22251-22255.